Role of parthenolide in paclitaxel-induced oxidative stress injury and impaired reproductive function in rat testicular tissue.

Oxidative stress Paclitaxel Parthenolide Testicular toxicity

Journal

Chemico-biological interactions
ISSN: 1872-7786
Titre abrégé: Chem Biol Interact
Pays: Ireland
ID NLM: 0227276

Informations de publication

Date de publication:
08 Nov 2023
Historique:
received: 23 08 2023
revised: 09 10 2023
accepted: 03 11 2023
pubmed: 11 11 2023
medline: 11 11 2023
entrez: 10 11 2023
Statut: aheadofprint

Résumé

The chemotherapeutic agent paclitaxel (PTX) causes testicular toxicity due to oxidative stress. Parthenolide (PTL), the active ingredient of the Tanacetum parthenium plant, is used to treat inflammation, dizziness, and spasms. In the present study, we evaluated the therapeutic effect of PTL on PTX-induced testicular toxicity in rats and its role in reproductive function. To this end, 6 groups were formed: control, PTX, sham, T1, T2, and T3. After testicular toxicity was induced in rats with 8 mg/kg PTX, the rats were treated with 1 mg/kg, 2 mg/kg, and 4 mg/kg PTL for 14 days. GSH and MDA levels were measured in rat testicular tissue after the last dose of PTL was administered. To determine the damage caused by PTX to testicular tissue by detecting 8-OHdG and iNOS, sections were prepared and examined histopathologically and immunohistochemically. Furthermore, the gene expressions and enzymatic activities of SOD, CAT, GPx, GST, and GR were investigated in all groups. After PTL treatment, MDA, 8-OHdG, and iNOS levels decreased while GSH levels increased in testicular tissue. Increased levels of antioxidant genes and enzymes also reduced oxidative stress. Additionally, the expression levels of the Dazl, Ddx4, and Amh genes, which are involved in gametogenesis and sperm production, decreased in case of toxicity and increased with PTL treatment. The data from this study show that PTL may have a therapeutic effect in the treatment of testicular damage by eliminating the oxidative stress-induced damage caused by PTX in testicular tissue, providing an effective approach to alleviating testicular toxicity, and playing an important role in reproduction/sperm production, especially at a dose of 4 mg/kg.

Identifiants

pubmed: 37949423
pii: S0009-2797(23)00460-X
doi: 10.1016/j.cbi.2023.110793
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110793

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Emine Toraman (E)

Atatürk University, Science Faculty, Department of Molecular Biology and Genetics, Erzurum, Turkey. Electronic address: emine.toraman@atauni.edu.tr.

Büşra Budak (B)

Atatürk University, Faculty of Medicine, Department of Obstetrics and Gynaecology, Erzurum, Turkey.

Cemil Bayram (C)

Atatürk University, Faculty of Medicine, Department of Medical Pharmacology, Erzurum, Turkey.

Selma Sezen (S)

Ağrı İbrahim Çeçen University, Faculty of Medicine, Department of Medical Pharmacology, Ağrı, Turkey.

Behzad Mokhtare (B)

Atatürk University, Faculty of Veterinary Medicine, Department of Veterinary Pathology, Erzurum, Turkey.

Ahmet Hacımüftüoğlu (A)

Atatürk University, Faculty of Medicine, Department of Medical Pharmacology, Erzurum, Turkey.

Classifications MeSH